Lumibird Medical announced the launch of Omnicad, a new-generation imaging platform with integrated artificial intelligence (AI) algorithms for aided diagnosis in ocular surface disease (OSD). The device is available exclusively in the US market and is designed to meet the needs of optometrists and ophthalmologists with complete exams in pre and post OSD treatment, the company said in a press release. 

According to Delphine Southon, dry eye product manager at Lumibird Medical, the Omnicad integrates multiple exams such as transillumination meibography and features an autofocus HD camera for sharp image quality and automatic, accurate and reproducible results. In addition, she says, the incorporated AI is based on algorithms derived from more than one million clinically validated images.

Health-care professionals attending the AAO Congress in Chicago (Oct. 18-21) will have the opportunity to discover the Omnicad platform at Lumibird Medical’s booth #5221.